Determinants of Staphylococcus aureus nasal carriage.
This article aims to review what is currently known of the host and bacterial factors determining S. aureus nasal carriage, including recent developments and future prospects.
Nouwen
J L
JL
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. nouwen@bacl.azr.nl
van Belkum
A
A
Verbrugh
H A
HA
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000453:epidemiology* / Q000517:prevention & control; D004197:Disease Reservoirs; D005544:Forecasting; D014943:Global Health; D006801:Humans; D016106:Methicillin Resistance; D016712:Mupirocin / Q000627:therapeutic use; D009297:Nasal Mucosa / Q000382:microbiology*; D011159:Population Surveillance; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control; D013211:Staphylococcus aureus; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D016712:Mupirocin